AIR TREATMENT


volume into a highly concentrated, uniform photon field, eliminating geometric shadowing entirely.


n VPER is not photocatalysis: PCO requires a physical catalytic substrate and is limited by surface-area contact and humidity variables. VPER reactions occur homogeneously throughout the passing air volume, completely independent of two-dimensional surfaces.


It is an irrefutable physical fact that photons, by orders of magnitude, outperform energetic electrons in terms of destructive efficacy and baseline energy conservation during the decomposition of molecular pollutants and the reduction of biological pathogens. While high- voltage electronic bombardment (plasma) relies on highly restricted, localized microzones of thermal kinetic transfer that inevitably risk generating hazardous environmental byproducts, a confined multi-pass photonic field forces immediate, non-thermal molecular bond cleavage uniformly across an entire spatial volume. By trapping this multi-wavelength photon flux inside a highly diffuse reflective matrix, the quantum efficiency is scaled exponentially, achieving absolute microbial clearance at a mere fraction of the electrical power required by electron- driven ionization platforms.


NHS operational evaluation and byproduct containment Theoretical physics must be verified by clinical reality. The VPER category, implemented within the MACH Purifier, has undergone independently verified operational evaluation within NHS clinical environments, heavily backed by the development frameworks of Health Innovation North East and North Cumbria. These trials focused on two primary operational criteria: real-world microbiocide efficacy and occupational safety.


n Microbiological clearance kinetics In active testing under real-world hospital occupancy, the VPER system demonstrated rapid, sustained reductions in airborne bioburden. The confined multi-pass photon matrix consistently eliminated aerosolised bacterial and viral surrogates, achieving high log-reductions of colony- forming units (CFUs) without requiring high air velocity or restricted duct paths. The uniform spatial density of the integrated multi-wavelength field ensured that multi-drug resistant bacterial strains and viral particles were realised and neutralised on their first pass through the reactor core.


n The self-destruct wavelength cycle A primary hurdle for generic gas-activation systems is the control of secondary emissions. The VPER category handles this through a synchronized physical loop inside the confined multi-pass environment. Initial bands within the multi-wavelength array drive localised, short-lived gas- phase interactions inside the chamber to disrupt pathogen cell walls. Crucially, simultaneous complementary bands act as an internal catalytic destructor, processing transient compounds back into baseline atmospheric gases before the air mass exits the machine. The NHS operational review verified that the MACH Purifier registered zero residual emissions above strict workplace limits, allowing safe, continuous operation in occupied clinical zones under UKCA and CE conformity.


Strategic implications for healthcare estates management The introduction of VPER as a recognised scientific category could fundamentally change how estates teams approach building services engineering.


Infection risk mitigation Traditional infection control strategies focus heavily on manual surface disinfection and high room-air-exchange rates (ACPH). VPER provides active, continuous, volumetric air remediation directly within the occupied volume. By rapidly reducing the residence time of viable pathogens in the breathing zone, the system assists clinical teams during winter infection surges, respiratory outbreak vectors, and high-occupancy ward pressures.


n Ventilation optimisation and carbon reduction Increasing outdoor air intake to mitigate pathogens is highly inefficient, inflating building HVAC heating and cooling energy consumption. The VPER reactor achieves equivalent microbial clearance rates internally, allowing estates managers to safely optimise recirculation loops and maintain indoor air hygiene without structural duct modifications, upsized fans, or increased carbon loads.


n Operational sustainability Legacy mechanical systems impose a continuous financial and environmental burden via spent filter replacement, specialist hazardous waste disposal, and fan motor degradation due to high filter loading resistance. VPER operates as a solid-state, non-mechanical photonic reactor. It drastically reduces consumables waste, lowers systemic pressure drops, and provides a direct, measurable path toward achieving the NHS Net Zero and Green Plan objectives.


Conclusion: a new era for healthcare estates indoor air quality VPER represents a necessary engineering evolution. By moving away from unconfined, single-pass irradiation and inefficient, high-voltage gas ionisation, the Magee–Fenton Reactor solves the geometric limitations that have saturated legacy air treatment technologies for decades. Utilising a confined multi-pass coated core chamber


to transform a coordinated multi-wavelength array into a highly efficient photonic trap, VPER achieves rapid, uniform destruction of airborne pathogens at an ultra-low energy profile. Backed by independently verified NHS operational evaluations, official validation from Health Innovation North East and North Cumbria, and full UKCA/CE compliance, the MACH Purifier demonstrates that advanced optical engineering successfully bridges the gap between rigorous infection control and sustainable, energy-efficient healthcare estates management.


Bibliography n CIE (International Commission on Illumination). (2003).


CIE 155:2003 – Ultraviolet Air Disinfection in Occupied Spaces. ISBN 978-3-901906-25-1.


n Görner P., & Simon X. (2012). Fluorinated Polymers and PTFE Properties under Extreme Deep-UV Exposure. Journal of Applied Polymer Science, 126(S1), E230–E241.


n Kowalski W. J. (2009). Ultraviolet Germicidal Irradiation Handbook: UVGI for Air and Surface Disinfection. Springer- Verlag. DOI: 10.1007/978-3-642-01999-9.


n Sliney D. H. (2014). Photobiological Safety of Lamps and Lamp Systems: Rules for Professional Applications. Health Physics, 106(6), 725–733.


n UK Health and Safety Executive (HSE). (2021). EH40/2005 Workplace Exposure Limits: Containing the List of Workplace Exposure Limits for Use with the Control of Substances Hazardous to Health Regulations. HSE Books.


n CIBSE (Chartered Institution of Building Services Engineers). (2021). CIBSE Emerging Technologies Briefing: Ultraviolet Air Purification in Institutional Ventilation Systems. CIBSE Journal, 13(4), 42–45.


Stephen Darren Magee


Stephen Darren Magee is an ex Royal Air Force Biomedical Engineer, AP(D), and Trust Nominated Decontamination Lead specialising in medical device governance, photonic medicine, environmental hygiene science, and high reliability engineering. He is the Founder of Holistium Technologies and a senior NHS clinical engineering leader with expertise in innovation governance, medical device registration, and regulated healthcare technology management. Stephen is a STEM Ambassador, STEM Educator, PhD student mentor, and Lecturer in Medical Device Management & Registration, Decontamination Sciences, and Healthcare Engineering Management. He is also the inventor of EC Quantum Control PDT, a drug free photonic medical technology designed as a non- invasive therapeutic alternative or adjunct to surgery, radiotherapy, and chemotherapy, and the originator of the Protein First (P1) Composite CFU Surrogate, a contamination risk model for environmental hygiene assessment in clinical and laboratory environments.


November 2026 Health Estate Journal 37


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72